ADC Therapeutics SA (ADCT) reported Q1 EPS of ($0.36), $0.34 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $46.5 million versus the consensus estimate of $28.94 million.
ADC Therapeutics SA (ADCT) reported Q1 EPS of ($0.36), $0.34 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $46.5 million versus the consensus estimate of $28.94 million.